8 Jul, 2015

Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, announces its meetings with the investors and shareholders during the second semester 2015.

September 16, 2015 11:30am: - Analyst and Investor Meeting

5:30pm: Audio/web conference

September 22, 2015 InvestorDagen

Radisson Blu Scandinavia Hotel - Copenhagen, Denmark

October 7 & 8, 2015 European Large & Midcap Event

Palais Brongiart, Paris

November 5, 2015 Société Générale CIB Healthcare & Biotechnology Conference

Pavillon Ledoyen, Paris

November 20 & 21, 2015 Salon Actionaria

Palais des Congrès, Paris

November 24, 2015 Natixis Small & Mid Caps Conference

Pavillon Gabriel, Paris

150708EN_Onxeo agenda S2 2015

OnxeoS.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), et innovativt selskab med speciale i udvikling af lægemidler til behandling af sjældne kræftsygdomme, har i dag offentliggjort en oversigt over møder med investorer og aktionærer i 2. halvår 2015.


16. september 2015 11.30 - Møde med analytikere og investorer

17.30 - Audio/web-konference

22. september 2015 InvestorDagen

Radisson Blu Scandinavia Hotel - København, Danmark

7. og 8. oktober 2015 European Large & Midcap Event

Palais Brongiart, Paris

5. november 2015 Société Générale CIB Healthcare & Biotechnology Conference

Pavillon Ledoyen, Paris

20. og 21. november 2015 Salon Actionaria

Palais des Congrès, Paris

24. november 2015 Natixis Small & Mid Caps Conference

Pavillon Gabriel, Paris

150708DK_Onxeo agenda S2 2015

distributed by